TickerFacts.

ADC Therapeutics SA (ADCT): Shareholders' Equity

Annual figures by period end, from SEC filings.

-$185.83M
As of 2025-12-31
-$228.21M
As of 2026-06-30
$79.45M2022-12-31: $79.45M2023-12-31: -$148.25M2024-12-31: -$202.64M2025-12-31: -$185.83M-$185.83M
2022-12-31 Shareholders' Equity (USD) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31-$185.83Mn/m2026-03-10, Balance as of period end
2024-12-31-$202.64Mn/m2026-03-10, Balance as of period end
2023-12-31-$148.25Mn/m2025-03-27, Balance as of period end
2022-12-31$79.45Mn/a2024-03-13, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
ADC Therapeutics SA (ADCT)2025-12-31-$185.83Mn/m
Arcturus Therapeutics Holdings Inc. (ARCT)2025-12-31$213.99M-11.2%
Eton Pharmaceuticals, Inc. (ETON)2025-12-31$26.15M+7.1%
Nurix Therapeutics, Inc. (NRIX)2025-11-30$538.75M+2.2%
ARS Pharmaceuticals, Inc. (SPRY)2025-12-31$114.26M-55.5%
Standard Biotools Inc. (LAB)2025-12-31$424.29M-10.1%
CytomX Therapeutics, Inc. (CTMX)2025-12-31$99.01Mn/m
Cytokinetics Inc (CYTK)2025-12-31-$659.62Mn/m
AbCellera Biologics Inc. (ABCL)2025-12-31$966.90M-8.4%

Compare ADCT, ARCT, ETON, NRIX side by side · Screen every company in Pharmaceutical Preparations ↗